Imodium Duo

Loperamide Hydrochloride and Dimeticone, the active ingredients in Imodium Duo, are a peripheral opioid receptor agonist and anti‑foaming agent presented as 2 mg/125 mg chewable tablets for oral use. It treats acute diarrhea, traveler's diarrhea and abdominal discomfort due to gas in adults and children over a certain age, providing rapid symptom relief and reducing the frequency of loose stools.

GNH USA supplies Imodium Duo as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with established distribution networks across Europe, Asia and Africa.

Imodium Duo, an antidiarrheal agent acting on intestinal motility and gas formation, is indicated for the following conditions: - Acute diarrhea: reduces stool frequency and improves consistency in adults and children. - Traveler's diarrhea: provides rapid relief of loose stools and abdominal cramping during travel. - Gas‑related abdominal discomfort: alleviates bloating and pressure by facilitating gas elimination.

Common Side Effects: - Constipation: reduced bowel movements leading to hard stools. - Nausea: feeling of unease or upset stomach. - Abdominal cramps: mild to moderate discomfort in the abdomen. - Dry mouth: decreased salivation. - Dizziness: light‑headed sensation. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Severe constipation or intestinal obstruction: risk of blockage requiring medical attention. - Ileus: paralytic bowel condition. - Allergic reactions: rash, itching, swelling, or difficulty breathing. - Cardiac arrhythmia: irregular heart rhythm, especially with high plasma levels. - Toxic megacolon: rare, life‑threatening colon dilation.

Before using Imodium Duo, consider the following precautions: - Assess severity of diarrhea: ensure it is not caused by an infection requiring antibiotics. - Avoid use in patients with known hypersensitivity to loperamide or dimeticone. - Do not exceed recommended duration: typically not longer than 48 hours without medical advice. - Caution in patients with hepatic impairment: monitor for drug accumulation. - Avoid in children under 2 years: not recommended for this age group. - Store at ambient temperature below 25 °C: keep in the original pack, protect from moisture.

Imodium Duo may interact with other medicines as follows: Major Interactions (Avoid): - Concomitant use with potent CYP3A4 inhibitors (e.g., ketoconazole) may increase loperamide levels and risk of cardiac toxicity. - Co‑administration with other antidiarrheals (e.g., diphenoxylate) may cause additive opioid effects. Moderate Interactions (Monitor Closely): - Concurrent use with CNS depressants (e.g., benzodiazepines) may enhance drowsiness. - Use with drugs that prolong the QT interval (e.g., macrolide antibiotics) may increase arrhythmia risk. - Interaction with anticholinergic agents may worsen constipation.